Investor Presentaiton slide image

Investor Presentaiton

-10-2 Day 8 CRP change from base line -30- -20- 0- FB704A in Dual Indications FB704A Showed Reduction in Key Indicators for Both Indications Key indicators for CKD-induced CVD 10- Key indicator for Severe Asthma -40- Placebo FB704A Haptoglobin Vehicle FB704A low FB704A mid´ FB704A high C-Reactive Protein and Haptoglobin are reduced Neutrophils Vehicle FB704A low FB704A mid FB704A high Neutrophils are reduced | 25 ONENESS
View entire presentation